Literature DB >> 27372291

Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise?

Matthew R Kappus1, Mardeli Saire Mendoza2, Douglas Nguyen3, Valentina Medici4, Stephen A McClave5.   

Abstract

Sarcopenia, a loss of muscle mass, is being increasingly recognized to have a deleterious effect on outcomes in patients with chronic liver disease. Factors related to diet and the inflammatory nature of chronic liver disease contribute to the occurrence of sarcopenia in these patients. Sarcopenia adversely influences quality of life, performance, morbidity, success of transplantation, and even mortality. Specific deficiencies in macronutrients (protein, polyunsaturated fatty acids) and micronutrients (vitamins C, D, and E, carotenoids, and selenium) have been linked to sarcopenia. Lessons learned from nutritional therapy in geriatric patient populations may provide strategies to manage sarcopenia in patients with liver disease. Combining diet modification and nutrient supplementation with an organized program of exercise may help ameliorate or even reverse the effects of sarcopenia on an already complex disease process.

Entities:  

Keywords:  Cirrhosis; Liver disease; Malnutrition; Muscle wasting; Portal hypertension; Protein malnutrition; Sarcopenia

Mesh:

Substances:

Year:  2016        PMID: 27372291     DOI: 10.1007/s11894-016-0516-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  73 in total

1.  Muscle and mortality in cirrhosis.

Authors:  Toufic Kachaamy; Jasmohan S Bajaj; Douglas M Heuman
Journal:  Clin Gastroenterol Hepatol       Date:  2011-11-10       Impact factor: 11.382

Review 2.  Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia.

Authors:  A Dewey; C Baughan; T Dean; B Higgins; I Johnson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

Authors:  Yasutoshi Muto; Shunichi Sato; Akiharu Watanabe; Hisataka Moriwaki; Kazuyuki Suzuki; Akinobu Kato; Masahiko Kato; Teiji Nakamura; Kiyohiro Higuchi; Shuhei Nishiguchi; Hiromitsu Kumada
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

4.  Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment.

Authors:  B Campillo; P Fouet; J C Bonnet; G Atlan
Journal:  J Hepatol       Date:  1990-03       Impact factor: 25.083

5.  Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.

Authors:  Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

6.  Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus.

Authors:  Ichiro Konishi; Yoichi Hiasa; Yoshio Tokumoto; Masanori Abe; Shinya Furukawa; Kumiko Toshimitsu; Bunzo Matsuura; Morikazu Onji
Journal:  Hepatol Res       Date:  2011-06-28       Impact factor: 4.288

7.  Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy.

Authors:  Rachel A Murphy; Marina Mourtzakis; Quincy S C Chu; Vickie E Baracos; Tony Reiman; Vera C Mazurak
Journal:  Cancer       Date:  2011-02-28       Impact factor: 6.860

8.  Muscle wasting is associated with mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

9.  Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults.

Authors:  Elena Volpi; Hisamine Kobayashi; Melinda Sheffield-Moore; Bettina Mittendorfer; Robert R Wolfe
Journal:  Am J Clin Nutr       Date:  2003-08       Impact factor: 7.045

Review 10.  Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.

Authors:  Srinivasan Dasarathy
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199

View more
  13 in total

Review 1.  Hyperammonemia and proteostasis in cirrhosis.

Authors:  Srinivasan Dasarathy; Maria Hatzoglou
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-01       Impact factor: 4.294

2.  Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation.

Authors:  David M Chascsa; Jennifer C Lai; Michael A Dunn; Aldo J Montano-Loza; Matthew R Kappus; Srinivasan Dasarathy; Elizabeth J Carey
Journal:  Dig Dis Sci       Date:  2018-09-03       Impact factor: 3.199

3.  Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-06-18       Impact factor: 12.910

4.  Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices.

Authors:  Yoshiyuki Sakai; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

5.  Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy.

Authors:  Yukihisa Yuri; Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Cancer       Date:  2017-06-01       Impact factor: 4.207

6.  Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver Cirrhosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Nutrients       Date:  2017-06-12       Impact factor: 5.717

7.  Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

Authors:  Hitomi Takada; Masayuki Kurosaki; Hiroyuki Nakanishi; Yuka Takahashi; Jun Itakura; Kaoru Tsuchiya; Yutaka Yasui; Nobuharu Tamaki; Kenta Takaura; Yasuyuki Komiyama; Mayu Higuchi; Youhei Kubota; Wann Wang; Mao Okada; Nobuyuki Enomoto; Namiki Izumi
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

8.  Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases.

Authors:  Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Naoto Ikeda; Nobuhiro Aizawa; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Diagnostics (Basel)       Date:  2020-04-20

9.  Serum Zinc Level Classification System: Usefulness in Patients with Liver Cirrhosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Clin Med       Date:  2019-11-22       Impact factor: 4.241

Review 10.  A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.